跳至主要内容
临床试验/NCT03255785
NCT03255785已完成不适用

A Prospective Evaluation of Mild to Moderate Open-Angle Glaucoma Subjects With Cataract Treated With Cataract Surgery Plus One Trabecular Micro-bypass Stent and One Suprachoroidal Stent

Glaukos Corporation1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2018年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
1
主要终点
20% IOP reduction from baseline

研究概览

简要总结

Open Angle Glaucoma Subjects with Cataract treated with Cataract Surgery plus one trabecular micro-bypass stent and one suprachoroidal stent

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

盲法说明

IOP outcome masked

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Clinically significant cataract requiring surgery Primary open-angle or pseudoexfoliative glaucoma Visual field defects no worse than -12dB Subject on two ocular hypotensive medications at screening Medicated IOP at screening between 18 and 30 mm Hg Normal iridocorneal anatomy Absence of peripheral anterior synechiae

排除标准

  • •Monocular subjects or those with wore than 20/200 vision in fellow eye Prior stent implantation, incision glaucoma surgery, or laser trabeculoplasty in study eye Traumatic, uveitic, or neovascular glaucoma

研究组 & 干预措施

G1 plus G3 with phaco

Experimental

Cataract surgery via phacoemulsification followed by implantation of one iStent and one iStent Supra

干预措施: Cataract surgery plus one iStent and one iStent Supra implanted (Device)

结局指标

主要结局

20% IOP reduction from baseline

时间窗: Month 12

IOP measured via Goldmann tonometry in mm Hg and compared to baseline IOP

次要结局

  • IOP less than or equal to 18 mm Hg(Month 12)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验